Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.521
+0.011 (0.73%)
At close: Dec 30, 2025, 4:00 PM EST
1.520
-0.001 (-0.07%)
After-hours: Dec 30, 2025, 4:10 PM EST
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $2.73 million as of December 30, 2025. Its market cap has decreased by -6.86% in one year.
Market Cap
2.73M
Enterprise Value
-3.34M
1-Year Change
-6.86%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $2.73M, a decrease of -98.25%. That is a compound annual growth rate of -33.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 2.71M | 17.03% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.22B |
| Johnson & Johnson | 499.18B |
| AbbVie | 404.59B |
| UnitedHealth Group | 300.90B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 263.22B |
| Novo Nordisk | 227.80B |